Epigenetic events in tumorigenesis: Putting the pieces together

Experimental Oncology

Volumn 32, Issue 3, 2010, Pages 132-136

  Pogribny, I P ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Carcinogenesis; DNA methylation; Epigenetics; Histone methylation

Indexed keywords

TUMOR MARKER;

CANCER DIAGNOSIS; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; REVIEW;

ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS;

EID: 77957737086     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
2. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10: 789-99. (Pubitemid 39070849)
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-92.
4. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31: 27-36.
5. Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-59.
6. Feinberg AP. Epigenetics at the epicenter of modern medicine. JAMA 2008; 299: 1345-50.
7. Miller JA. Carcinogenesis by chemicals: an overview - G.H.A. Clowes memorial lecture. Cancer Res 1970; 30: 559-76.
8. Ooi SK, O'Donnell AH, Bestor TH. Mammalian cytosine methylation at a glance. J Cell Sci 2009; 122: 2787-91.
9. Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 2009; 10: 805-11.
10. Rollins RA, Haghighi F, Edwards JR, et al. Large-scale structure of genomic methylation patterns. Genome Res 2006; 16: 157-63. (Pubitemid 43200263)
11. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705.
12. Lennartsson A, Ekwall K. Histone modifications and epigenetic codes. Biochim Biophys Acta 2009; 1790: 863-8.
13. Robertson KD. DNA methylation and chromatin - unraveling the tangled web. Oncogene 2002; 21: 5361-79.
14. Ting AH, McGarvey KM, Baylin SB. The cancer epigenome - components and functional correlates. Genes Dev 2006; 20: 3215-31.
15. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 2009; 1: 239-59.
16. Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-9. (Pubitemid 32695003)
17. Hinshelwood RA, Clark SJ. Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J Mol Med 2008; 86: 1315-28.
18. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4: 988-93.
19. Moss TJ, Wallrath LL. Connections between epigenetic gene silencing and human disease. Mutat Res 2007; 618: 163-74.
20. Jaffe LF. Epigenetic theories of cancer initiation. Adv Cancer Res 2003; 90: 209-30.
21. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7: 21-33. (Pubitemid 41828945)
22. Gaudet F, Hodgson JG, Eden A, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300: 489-92. (Pubitemid 36444330)
23. Hervouet E, Lalier L, Debien E, et al. Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS One 2010; 5: e11333.
24. Fan T, Schmidtmann A, Xi S, et al. DNA hypomethylation caused by LSH deletion promotes erythroleukemia development. Epigenetics 2008; 3: 134-42.
25. De Smet C, Loriot A. DNA hypomethylation in cancer: Epigenetic scars of neoplastic journey. Epigenetics 2010; 5: doi 10.4161/epi.5.3.11447.
26. Wild L, Flanagan JM. Genome-wide hypomethylation in cancer may be a passive consequence of transformation. Biochim Biophys Acta 2010; 1806: 50-7.
27. Yamada Y, Jackson-Grusby L, Linhart H, et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 2005; 102: 13580-5. (Pubitemid 41420891)
28. Tomita H, Hirata A, Yamada Y, et al. Suppressive effect of global DNA hypomethylation on gastric carcinogenesis. Carcinogenesis 2010; doi bgq129v1-bgq129.
29. Chen RZ, Pettersson U, Beard C, et al. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395: 89-93. (Pubitemid 28420236)
30. Eden A, Gaudet F, Waghmare A, et al. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455. (Pubitemid 36444319)
31. Howard G, Eiges R, Gaudet F, et al. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008; 27: 404-8.
32. Feinberg AP, Cui H, Ohlsson R. DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin Cancer Biol 2002; 12: 389-98.
33. Sharrard RM, Royds JA, Rogers S, et al. Patterns of methylation of the c-myc gene in human colorectal cancerprogression. Br J Cancer 1992; 65: 667-72.
34. Jenuwein T. The epigenetic magic of histone lysine methylation. FEBS J 2006; 273: 3121-35.
35. Jacinto FV, Esteller M. Mutator pathways unleashed by epigenetic silencing in human cancer. Mutagenesis 2007; 22: 247-53. (Pubitemid 47216613)
36. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60: 2368-71.
37. 6-methylguanine-DNA methyltransferase is associated with the presence G:C to A:T transition mutations in p53 human colorectal tumorigenesis. Cancer Res 2001; 61: 4689-92.
38. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, et al. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 2006; 8: R38. (Pubitemid 44057561)
39. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95: 6870-5. (Pubitemid 28278073)
40. Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis 2008; 24: 117-25.
41. Shuker DE. The enemy at the gates? DNA adducts as biomarkers of exposure to exogenous and endogenous genotoxic agents. Toxicol Lett 2002; 134: 51-6.
42. Silva LB, Van der Laan JW. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard. Regul Toxicol Pharmacol 2000; 32: 135-43.
43. Zheng H, Shank RC. Changes in methyl-sensitive restriction sites of liver DNA from hamsters chronically exposed to hydrazine sulfate. Carcinogenesis 1996; 17: 2711-7. (Pubitemid 27037630)
44. Zhao CQ, Young MR, Diwan BA, et al. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 1997; 94: 10907-12.
45. Belinsky SA, Snow SS, Nikula KJ, et al. Aberrant CpG island methylation of the p16 (INK4a) and estrogen receptor genes in rats lung tumors induced by particulate carcinogens. Carcinogenesis 2002; 23: 335-9.
46. Belinsky SA, Kinge DM, Liechty KC, et al. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis 2004; 25: 1063-7.
47. Bachman AN, Phillips JM, Goodman JI. Phenobarbital induces progressive patterns of CG-rich and genespecific altered DNA methylation in the liver of tumor-prone B6C3F1 mice. Toxicol Sci 2006; 91: 393-405.
48. Pogribny IP, Tryndyak VP, Woods CG, et al. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha. Mutat Res 2007; 625: 62-71.
49. Salnikov K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008; 21: 28-44. (Pubitemid 351219706)
50. Bagnyukova TV, Tryndyak VP, Montgomery B, et al. Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene. Carcinogenesis 2008; 29: 638-46. (Pubitemid 351404882)
51. Liu WB, Liu JY, Zhou ZY, et al. Dynamic changes in DNA methylation during multistep rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Toxicol Lett 2009; 189: 5-13.
52. Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007; 67: 876-880. (Pubitemid 46270740)
53. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009; 21: 243-51.
54. Wright RO, Schwartz J, Wright RJ, et al. Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ Health Perspect 2010; 118: 790-5.